Zacks
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock?
📈
AI Sentiment
Highly Positive
8/10
- Home
- OM
as of 01-16-2026 3:35pm EST
$5.20
$0.06
-1.14%
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 96.2M | IPO Year: | 2020 |
| Target Price: | $14.00 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.60 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.10 - $21.98 | Next Earning Date: | 02-18-2026 |
| Revenue: | $120,069,000 | Revenue Growth: | 4.65% |
| Revenue Growth (this year): | 6.23% | Revenue Growth (next year): | 8.87% |
AI-Powered OM Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 0.00%
0.00%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Outset Medical Inc. (OM)
Trigg Leslie
Sell
Chair and CEO
OM Jan 7, 2026
Avg Cost/Share
$4.27
Shares
1,795
Total Value
$7,664.65
Owned After
119,617
SEC Form 4
Brottem John L.
Sell
General Counsel
OM Jan 7, 2026
Avg Cost/Share
$4.27
Shares
224
Total Value
$956.48
Owned After
46,271
SEC Form 4
Drexler Karen
Sell
Director
OM Dec 1, 2025
Avg Cost/Share
$4.37
Shares
1,548
Total Value
$6,764.76
Owned After
10,650
SEC Form 4
Trigg Leslie
Sell
Chair and CEO
OM Nov 17, 2025
Avg Cost/Share
$4.60
Shares
916
Total Value
$4,213.60
Owned After
119,617
SEC Form 4
Brottem John L.
Sell
General Counsel
OM Nov 17, 2025
Avg Cost/Share
$4.60
Shares
388
Total Value
$1,784.80
Owned After
46,271
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Nash Marc | OM | EVP Operations R&D & Service | Jan 7, 2026 | Sell | $4.27 | 108 | $461.16 | 48,160 | |
| Trigg Leslie | OM | Chair and CEO | Jan 7, 2026 | Sell | $4.27 | 1,795 | $7,664.65 | 119,617 | |
| Brottem John L. | OM | General Counsel | Jan 7, 2026 | Sell | $4.27 | 224 | $956.48 | 46,271 | |
| Drexler Karen | OM | Director | Dec 1, 2025 | Sell | $4.37 | 1,548 | $6,764.76 | 10,650 | |
| Nash Marc | OM | EVP Operations R&D & Service | Nov 17, 2025 | Sell | $4.60 | 247 | $1,136.20 | 48,160 | |
| Trigg Leslie | OM | Chair and CEO | Nov 17, 2025 | Sell | $4.60 | 916 | $4,213.60 | 119,617 | |
| Brottem John L. | OM | General Counsel | Nov 17, 2025 | Sell | $4.60 | 388 | $1,784.80 | 46,271 |
Latest Outset Medical Inc. News
OM Breaking Stock News: Dive into OM Ticker-Specific Updates for Smart Investing
GlobeNewswire
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
📈
AI Sentiment
Highly Positive
8/10
Compare OM vs Leading Stocks
See how OM stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "OM Outset Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.